Synapsoft logo
AI Insights from Disclosures
Searching...
STCUBE 052020
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
STCUBE engages in three segments: the Bio business, in which it researches anticancer immunotherapy, immune checkpoint inhibitors, and antibody and small-molecule compound treatments together with researchers at its subsidiary STCube Pharmaceuticals, Inc (USA); the Cosmetics business, covering cosmetics manufacturing and sale, cosmetics distribution, and e-commerce; and the Distribution business, which sells industrial Lens Modules and printers. Within the Distribution business, industrial Lens Modules, which accounted for about 49% of sales in the current half-year, are the company's flagship product, imported from China and Japan and distributed to domestic companies.
Representative Director Jung Hyeonjin
Founded August 16, 1989
Corporation Type KOSDAQ
Industry Classification Wholesale of machinery, equipment and supplies
Corporate number 12431-0025472
Business number 130-81-26197
Phone Number 02-551-3370
Fax Number 02-551-3374
Website www.stcube.com
Company Address 511 Yeongdong-daero, Gangnam-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant